ATE184597T1 - Substituierte sulfonamide, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents

Substituierte sulfonamide, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE184597T1
ATE184597T1 AT95400384T AT95400384T ATE184597T1 AT E184597 T1 ATE184597 T1 AT E184597T1 AT 95400384 T AT95400384 T AT 95400384T AT 95400384 T AT95400384 T AT 95400384T AT E184597 T1 ATE184597 T1 AT E184597T1
Authority
AT
Austria
Prior art keywords
production
pharmaceutical compositions
compositions containing
substd
formula
Prior art date
Application number
AT95400384T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Jean-Paul Vilaine
Nicole Villeneuve
Jean-Pierre Iliou
Jean-Pierre Bidouard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE184597T1 publication Critical patent/ATE184597T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/66Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
AT95400384T 1994-02-25 1995-02-23 Substituierte sulfonamide, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen ATE184597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402159A FR2716679B1 (fr) 1994-02-25 1994-02-25 Nouvelles sulfonamides substituées, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US08/393,452 US5565457A (en) 1994-02-25 1995-02-23 Substituted sulfonamides

Publications (1)

Publication Number Publication Date
ATE184597T1 true ATE184597T1 (de) 1999-10-15

Family

ID=26230972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95400384T ATE184597T1 (de) 1994-02-25 1995-02-23 Substituierte sulfonamide, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen

Country Status (16)

Country Link
US (1) US5565457A (de)
EP (1) EP0669322B1 (de)
JP (1) JPH07258217A (de)
CN (1) CN1053895C (de)
AT (1) ATE184597T1 (de)
AU (1) AU682428B2 (de)
CA (1) CA2143249C (de)
DE (1) DE69512104T2 (de)
DK (1) DK0669322T3 (de)
ES (1) ES2139156T3 (de)
FI (1) FI110364B (de)
FR (1) FR2716679B1 (de)
GR (1) GR3031256T3 (de)
NO (1) NO302571B1 (de)
NZ (1) NZ270567A (de)
ZA (1) ZA951577B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
FR2804429B1 (fr) * 2000-01-31 2003-05-09 Adir Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2439634A1 (en) * 2001-03-01 2002-09-12 Technological Resources Pty Limited Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
US20040266732A1 (en) * 2002-09-20 2004-12-30 Jorge Galvez Therapeutic agents, methods, and treatments
US20070043079A1 (en) * 2003-04-18 2007-02-22 Hiromu Habashita Heterocyclic compound containing nitrogen atom and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527768A (en) * 1967-11-24 1970-09-08 Monsanto Co Sulfonamido coumarin compounds
JP2556722B2 (ja) * 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5326870A (en) * 1991-02-13 1994-07-05 Asahi Kasei Kogyo Kabushiki Kaisha Substituted sulfonamide derivative and a pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
ZA951577B (en) 1995-12-12
FI950818A0 (fi) 1995-02-22
GR3031256T3 (en) 1999-12-31
DE69512104T2 (de) 2000-04-20
NO950716D0 (no) 1995-02-24
US5565457A (en) 1996-10-15
NO950716L (no) 1995-08-28
CA2143249A1 (fr) 1995-08-26
NO302571B1 (no) 1998-03-23
DK0669322T3 (da) 2000-03-27
FI110364B (fi) 2002-12-31
AU1344995A (en) 1995-09-07
FR2716679A1 (fr) 1995-09-01
CN1120537A (zh) 1996-04-17
EP0669322A1 (de) 1995-08-30
NZ270567A (en) 1996-05-28
JPH07258217A (ja) 1995-10-09
CA2143249C (fr) 2002-02-26
AU682428B2 (en) 1997-10-02
EP0669322B1 (de) 1999-09-15
ES2139156T3 (es) 2000-02-01
DE69512104D1 (de) 1999-10-21
FR2716679B1 (fr) 1996-04-05
FI950818A (fi) 1995-08-26
CN1053895C (zh) 2000-06-28

Similar Documents

Publication Publication Date Title
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
ATE159721T1 (de) Verzweigte alkylaminothiazolederivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten
FI950016A0 (fi) Heterosykliset yhdisteet lääkeaineena
MX9300745A (es) Nuevos azaindoles, procedimiento para su preparacion y productos medicinales que los contienen.
DE69210029D1 (de) Azacyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE163919T1 (de) Naphthalen-derivate mit affinität für melatonin- rezeptoren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DK0759919T3 (da) Azolidindioner som antihyperglykæmiske midler
BR9704900A (pt) Compostos de vlavona processo para a sua preparação e composições farmacêuticas contendo os mesmos
ATE152707T1 (de) Neue naphthalin-amide und sulfonamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE184597T1 (de) Substituierte sulfonamide, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3773597D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT98688A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-(2-cloro-1-hidroxietil)-4-metiltiazol
DK702788A (da) Thioformamidderivater og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
PT93904A (pt) Processo para a preparacao de novos derivados benzotiazolinonicos e de composicoes farmaceuticas que os contem
ATE200488T1 (de) Thiophenverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ES2096931T3 (es) Derivados de 4-oxa-1-azabiciclo(3,2,0)heptan-7-ona utilizados como agentes antitumorales.
PT100104A (pt) Processo para a preparacao de aminoalcanos substituidos

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee